T1	Participants 62 116	patients with implantable cardioverter defibrillators.
T2	Participants 260 320	patients with implantable cardioverter defibrillators (ICDs)
T3	Participants 651 689	patients with inducible monomorphic VT
T4	Participants 710 722	172 patients
T5	Participants 843 861	patients with ICDs
T6	Participants 863 1017	The majority of patients had a history of documented remote myocardial infarction and congestive heart failure New York Heart Association class II or III.
T7	Participants 1660 1688	patients with implanted ICDs
